A. Polito

1.6k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

A. Polito is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, A. Polito has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 10 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in A. Polito's work include Hepatitis C virus research (19 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (8 papers). A. Polito is often cited by papers focused on Hepatitis C virus research (19 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (8 papers). A. Polito collaborates with scholars based in United States, Netherlands and Japan. A. Polito's co-authors include David Proud, S. Quan, W. P. Schaasberg, H. W. Reesink, P.N. Lelie, Michael Houghton, C.L. van der Poel, H.T.M. Cuypers, A Leentvaar-Kuypers and P.J. van Exel‐Oehlers and has published in prestigious journals such as The Lancet, Gut and Journal of Allergy and Clinical Immunology.

In The Last Decade

A. Polito

25 papers receiving 1.2k citations

Hit Papers

Confirmation of hepatitis C virus infection by new four-a... 1991 2026 2002 2014 1991 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Polito United States 18 890 798 171 160 133 26 1.3k
Gianfranco Santini Italy 17 544 0.6× 381 0.5× 91 0.5× 36 0.2× 216 1.6× 23 1.3k
Robert C. Tam United States 17 553 0.6× 477 0.6× 210 1.2× 25 0.2× 231 1.7× 28 1.2k
Nicolás Bianco Venezuela 20 238 0.3× 355 0.4× 86 0.5× 152 0.9× 138 1.0× 73 1.3k
P. C. Frei Switzerland 18 398 0.4× 426 0.5× 93 0.5× 71 0.4× 94 0.7× 65 1.1k
Yasuhiro Itsui Japan 20 920 1.0× 734 0.9× 157 0.9× 33 0.2× 378 2.8× 53 1.5k
Taisuke Inoue Japan 21 1.0k 1.2× 995 1.2× 254 1.5× 36 0.2× 166 1.2× 57 1.5k
Haruhisa Nakao Japan 24 916 1.0× 984 1.2× 102 0.6× 82 0.5× 338 2.5× 69 1.9k
P.L. Yap United Kingdom 15 936 1.1× 952 1.2× 656 3.8× 71 0.4× 138 1.0× 28 1.8k
M. Jung Germany 10 375 0.4× 467 0.6× 74 0.4× 77 0.5× 185 1.4× 15 1.2k

Countries citing papers authored by A. Polito

Since Specialization
Citations

This map shows the geographic impact of A. Polito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Polito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Polito more than expected).

Fields of papers citing papers by A. Polito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Polito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Polito. The network helps show where A. Polito may publish in the future.

Co-authorship network of co-authors of A. Polito

This figure shows the co-authorship network connecting the top 25 collaborators of A. Polito. A scholar is included among the top collaborators of A. Polito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Polito. A. Polito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polito, A., et al.. (2004). [Exanthematous outbreak caused by human parvovirus B19 in a school in Banderaló, Argentina].. PubMed. 35(3). 171–4. 5 indexed citations
2.
Fabrizi, F., Paul Martin, Vivek Dixit, et al.. (2001). Automated RIBA<sup>TM</sup> HCV Strip Immunoblot Assay: A Novel Tool for the Diagnosis of Hepatitis C Virus Infection in Hemodialysis Patients. American Journal of Nephrology. 21(2). 104–111. 3 indexed citations
3.
Tobler, Leslie H., Susan L. Stramer, Julie Peterson, et al.. (2000). Performance of second‐ and third‐generationRIBAs for confirmation of third‐generationHCV EIA‐reactive blood donations. Transfusion. 40(8). 917–923. 17 indexed citations
5.
Polito, A. & David Proud. (1998). Epithelial cells as regulators of airway inflammation. Journal of Allergy and Clinical Immunology. 102(5). 714–718. 196 indexed citations
6.
Bryan, Christopher, Gary E. Tegtmeier, A. Polito, et al.. (1996). Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donors.. PubMed. 28(1). 155–6.
7.
Vrielink, Hans, Hans L. Zaaijer, C.L. van der Poel, et al.. (1996). New Strip Immunoblot for the Confirmation of HTLV‐I/II Infection. Vox Sanguinis. 70(2). 114–116. 8 indexed citations
8.
Lane, Michael J., et al.. (1995). Increased detection of hepatitis C virus infection in commercial plasma donors by a third‐generation screening assay. Transfusion. 35(10). 845–849. 44 indexed citations
9.
Busch, MP, Judith C. Wilber, Robert K. DiNello, et al.. (1994). Evaluation of indeterminate c22‐3 reactivity in volunteer blood donors. Transfusion. 34(2). 130–134. 44 indexed citations
10.
Baskin, Gordon S., Robert K. DiNello, A. Polito, et al.. (1993). Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results.. Gut. 34(2 Suppl). S61–S61. 1 indexed citations
11.
Busch, Michael P., Leslie H. Tobler, S. Quan, et al.. (1993). A pattern of 5‐1‐1 and c100‐3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors. Transfusion. 33(1). 84–88. 28 indexed citations
12.
Polito, A., et al.. (1993). Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation.. PubMed. 25(1 Pt 2). 1469–71. 31 indexed citations
13.
Evans, Cherie S., Leslie H. Tobler, A. Polito, et al.. (1992). Comparative evaluation of supplemental hepatitis C virus antibody test systems. Transfusion. 32(5). 408–414. 27 indexed citations
14.
Kleinman, Steven, et al.. (1992). Increased detection of hepatitis C virus (HCV)‐infected blood donors by a multiple‐antigen HCV enzyme immunoassay. Transfusion. 32(9). 805–813. 133 indexed citations
15.
Poel, C.L. van der, Dorine Bresters, H. W. Reesink, et al.. (1992). Early Antihepatitis C Virus Response with Second—Generation C200/C22 ELISA. Vox Sanguinis. 62(4). 208–212. 49 indexed citations
16.
Poel, C.L. van der, H. W. Reesink, H.T.M. Cuypers, et al.. (1991). Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. The Lancet. 337(8737). 317–319. 425 indexed citations breakdown →
18.
Poel, Chris van der, H.T.M. Cuypers, H. W. Reesink, et al.. (1991). Risk factors in hepatitis C virus‐infected blood donors. Transfusion. 31(8). 777–779. 44 indexed citations
19.
Busch, Michael P., et al.. (1991). Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant‐antigen immunoblot assay. Transfusion. 31(2). 129–137. 19 indexed citations
20.
O’Connor, John D., et al.. (1970). Characterization of invertebrate sphingolipid bases: occurrence of eicosasphinga-4, 11-dienine and eicosasphing-11-enine in scorpion. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 202(1). 195–197. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026